Stock Incentive Plans (Tables)

9 Months Ended

Sep. 30, 2022

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Summary of Share-based Compensation Arrangements by Share-based Payment Award

The table below summarizes the option activity for the nine months ended September 30, 2022:

						Weighted-
						Average
				Weighted-		Remaining		Aggregate
				Average		Contractual		Intrinsic
				Exercise		Life		Value
	Shares			Price		(in years)		(in thousands)
Options outstanding—December 31, 2021		55,644,495		$	2.95		6.0	$	469,591
Exercised		(8,367,100	)		2.73
Forfeited and canceled		(272,295	)		4.64
Options outstanding—September 30, 2022		47,005,100		$	2.98		5.2	$	287,659
Options exercisable—September 30, 2022		43,168,788		$	2.73		4.9	$	274,947
Options vested and expected to vest—September 30, 2022		46,752,866		$	2.96		5.1	$	286,840

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The valuation of the performance-based RSUs with a market condition granted during the nine months ended September 30, 2022 was determined using a Monte Carlo simulation model using the following assumptions:

Expected term (in years)	2.8
Expected volatility	35%
Expected dividend yield	0%
Risk-free interest rate	2.28%

Schedule of Non-vested Restricted Stock Units Activity

The table below summarizes the RSU activity for the nine months ended September 30, 2022:

				Weighted-
				Average
	Shares			Fair Value
Non-vested RSUs—December 31, 2021		18,558,211		$	10.74
Granted		15,824,517			10.13
Vested		(2,081,478	)		11.36
Forfeited		(963,556	)		11.02
Non-vested RSUs—September 30, 2022		31,337,694			10.38

Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount

Stock-Based Compensation—Stock-based compensation expense has been recorded in the accompanying condensed consolidated statements of operations and comprehensive income (loss) as follows for the three and nine months ended September 30, 2022 and 2021 (in thousands):

	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
	2022		2021		2022		2021
Cost of revenues	$	1,657	$	12,169	$	4,167	$	12,563
Research and development		5,373		35,472		14,433		36,748
Sales and marketing		6,890		58,770		18,331		60,060
General and administrative		14,802		113,465		43,838		126,042
Total stock-based compensation expense	$	28,722	$	219,876	$	80,769	$	235,413

Ccc2021 Employee Stock Purchase Plan [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of ESPP purchase rights sold during the nine months ended September 30, 2022 was estimated using the Black Scholes option pricing model with the following assumptions:

Expected term (in years)	0.5
Expected volatility	47%
Expected dividend yield	0%
Risk-free interest rate	0.2%